# FDA Inspection 1034791 - Octapharma Plasma, Inc. - November 30, 2017

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/c503e5c6-4928-4700-bb00-863b3c8c67b3
Source feed: FDA_Inspections

> FDA Inspection 1034791 for Octapharma Plasma, Inc. on November 30, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1034791
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2017-11-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 832266 - 2013-05-09](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/f37f5083-052a-40fd-b845-d6bcb4a24b7e)
- [FDA Inspection 755956 - 2011-12-02](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/73289ed2-c6d1-43a4-949e-3c8067d9a931)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/de3583bd-21cb-403f-8a0e-933839c0b3bf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d